<DOC>
	<DOC>NCT01177644</DOC>
	<brief_summary>This study will evaluate the safety and preliminary effectiveness of PDS 1.0 in patients with neovascular AMD.</brief_summary>
	<brief_title>Safety and Preliminary Efficacy Study of PDS-1.0 in Patients With Neovascular AMD</brief_title>
	<detailed_description />
	<mesh_term>Macular Degeneration</mesh_term>
	<criteria>Key Diagnosis of CNV secondary to AMD confirmed by fluorescein angiography, not previously treated Retinal thickness due to edema of at least 300um in the study eye Best corrected visual acuity of 20/80 or worse in the study eye Best corrected visual acuity of 20/40 or better in the fellow eye Evidence of scarring CNV (e.g. geographic atrophy) in the study eye Fibrosis &gt;75% of lesion area in the study eye</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2012</verification_date>
</DOC>